Preprint / Version 1

Potential role of Curcumin against viral infections with a view on structure and pathogenesis of COVID-19


  • Kajal Singh Department of Bioanalytical Sciences, Ramnarain Ruia Autonomous College, Mumbai, India



A novel Coronavirus disease 2019 (nCOVID-19) is an enveloped, positive sense, single stranded RNA viruses of zoonotic origin caused by Severe acute respiratory syndrome coronavirus, currently responsible for pandemic health crisis. Due to increasing mortality rate there is an immediate need to develop possible treatments and understand the mechanism through which virus can cause complications in human body. The review intended to provide link between natural product as treatment and COVID-19 disease. Therefore, this review summarizes the structure, pathogenesis as well as understanding the various role of curcumin as a treatment option for COVID-19 which includes: targeting viral entry to host cells, targeting viral replication, anti-viral, anti-inflammatory and anti-oxidant. Hence, curcumin can be a potential treatment option for COVID-19 patients and this review also suggest that more clinical research and development is needed in order to prepare a new drug for emerging SARS-CoV-2.


COVID-19, angiotensin-converting enzyme II (ACE2), Curcumin


Download data is not yet available.


Cornelia C. Bergmann, Robert H. Silverman, “COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies,” Cleveland Clinic Journal of Medicine, Vol.87, Issue. 6, pp. 321-327, 2020.

Diana Moria. M., Joseph Badys. M., “COVID-19 Pandemic: The Origin, Transmission, Pathogenesis, and Therapeutic Application” AIJR Preprints, 161, version. 1, 2020. DOI:

Fatemeh. Z, Seyede. H., et al., “Potential effects of curcumin in the treatment of COVID-19 infection,” Journal of Phytotherapy Research, pp.1-10, 2020. doi: 10.1002/ptr.6738 [Epub ahead of print]

Yamuna. M., Vikram. H., et al., “Curcumin: A Wonder Drug as a Preventive Measure for COVID19 Management,” Indian Journal of Clinical Biochemistry, Vol.35, Issue. 3, pp.373-375, 2020.

Gamal El-Din A., Mamdouh F., “Potential repurposed SARS-CoV-2 (COVID-19) infection drugs,” Journal of Royal Society of Chemistry, Vol.10, Issue.45, pp. 26895-26916, 2020.

Hussain. R., Siddappa. N., “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak,” Journal of Autoimmunity, Vol.109, 2020. doi: 10.1016/j.jaut.2020.102433

Ridwane Mungroo. M, Naveed Ahmed. K, Ruqaiyyah. S., “Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options,” Journal of Multidisciplinary Digital Publishing Institute, Vol.9, Issue.4, pp.297, 2020.

Yuefei. J., Haiyan.Y., et al., “Virology, Epidemiology, Pathogenesis, and Control of COVID-19,” Journal of Viruses, Vol. 12, Issue.4, 2020.

Xiaowei. Li., Manman. G., et al., “Molecular immune pathogenesis and diagnosis of COVID-19,” Journal of Pharmaceutical Analysis, Vol. 10, Issue.2, pp. 102-108, 2020.

Yan-Rong. G., Qing-Dong. C., et al., “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status,” Journal of Military Medical Research, Vol.7, 2020. doi: 10.1186/s40779-020-00240-0.

Amit S. Lokhande, “Addressing COVID-19 Immune Storm: A Way Forward”, AIJR Preprints, 163, version. 1, 2020.

Anupam. R., Biswatrish. S., et al., “Can concomitant use of zinc and curcumin with other immunity?boosting nutraceuticals be the arsenal against COVID ?19,” Journal of Phytotherapy Research.,.

Padmanaban S. Suresh, “Curcumin and Coagulopathy in the COVID19 Era,” Indian Journal of Clinical Biochemistry, pp. 1-2, 2020. doi: 10.1007/s12291-020-00914-5 [Epub ahead of print]

Atala Jena. B., Namrata. K., et al., “Catechin and Curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane: insights from Computational study and implication for intervention,” Journal of Research Square, 2020. doi: 10.21203/

Ziteng. L., Ying. Y., “The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia,” Journal of Front Cell and Developmental Biology, Vol.8, 2020. doi: 10.3389/fcell.2020.